Panel Discussion: What’s Next for MASH Drug Development: Deep Diving into Innovations in the Field
Time: 3:45 pm
day: Conf Day 2 PM
Details:
- What are the future directions of MASH drug development?
- From GLP agonists, RNA therapies, AAV and SNPs which of these therapies hold the most promise
- Which pipelines should be prioritized?
